REAC® Technology was created by Rinaldi Fontani Institute.
ASMED Srl, is the only certified company authorized to manufacture medical devices based on REAC® Technology (Radio Electric Asymmetric Conveyer). The company operates globally, both directly and indirectly, through subsidiaries/controlled companies, joint ventures, licensing agreements, and distribution agreements.
This Privacy Policy aims to describe the operating procedures of this website regarding the processing of personal data of users/visitors who access it.
In accordance with current privacy protection regulations, REAC® Technology intends to guarantee the confidentiality and security of each visitor's personal data, including access from abroad, in compliance with the terms of this policy and the Data Protection Policy adopted by the Group.
Unless otherwise specified, this Privacy Policy shall also be understood as applicable to those who interact with the services offered by the website.
Detailed information on personal data processing is provided, where necessary, on pages relating to individual services offered. Such information is intended to define the limits and methods of data processing for each service, based on which visitors may freely express their consent and potentially authorize data collection and subsequent use.
Please note that this Privacy Policy does not cover other websites that users may access through links.
The Data Controller is Istituto Rinaldi Fontani srl., a company with registered office at Via Belfiore, 43 – 50144 Florence - Italy.
Personal data may be processed by internal and external parties appointed as Data Processors and by Authorized Personnel for the requested service.
Contact for the Data Protection Officer: email: info@reactechnology.com
This website offers informational and interactive content. During site navigation, information relating to visitors may be acquired, as specified below:
The computer systems and software procedures responsible for operating this website acquire, during their normal operation, certain personal data whose transmission is implicit in the use of Internet communication protocols.
Such data includes: IP addresses, browser type used, operating system, domain name and addresses of websites from/to which access/exit was made, information about pages visited by users within the site, access time, time spent on each page, internal path analysis, and other parameters relating to the user's operating system and computer environment. This technical/computer data is collected and used exclusively in aggregate and anonymous form and may be used to ascertain responsibility in cases of alleged computer/telematic crimes against the site.
Data voluntarily and freely provided by visitors on the site to access and/or request a specific service.
In any case, before proceeding with service activation, appropriate information will be provided and, where necessary, consent for personal data processing will be obtained through opt-in and/or opt-out techniques provided by applicable privacy regulations.
Freely given consent may be revoked at any time, however, this will make it impossible to continue using the service in question.
Personal data processing occurs primarily using electronic procedures and media for the time strictly necessary to achieve the purposes for which it was collected and, in any case, in compliance with applicable regulatory/legislative provisions.
Cookies are information packets sent by a web server (such as the site) to the user's Internet browser, automatically saved by the browser on the computer and automatically sent back to the server at each subsequent site visit.
The default settings of almost all web browsers provide for automatic acceptance of cookies.
The website does not use cookies for transmitting personal information.
The use of session cookies (which are not stored persistently on the user's computer and disappear when the browser is closed) is strictly limited to transmitting session identifiers necessary to allow safe and efficient site exploration.
The session cookies used on this site avoid resorting to other computer techniques potentially harmful to user navigation privacy and do not allow acquisition of personal data identifying the user.
This site also uses persistent cookies, i.e., cookies that are stored on the computer's hard drive until their expiration or deletion by the user.
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V